| Bioactivity | N-Desmethyl imatinib (Norimatinib) is a metabolite of Imatinib (HY-15463). Imatinib is a multi-target inhibitor of v-Abl, c-Kit and PDGFR[1]. | ||||||||||||
| Name | N-Desmethyl imatinib | ||||||||||||
| CAS | 404844-02-6 | ||||||||||||
| Formula | C28H29N7O | ||||||||||||
| Molar Mass | 479.58 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Robert A Parise, et al. Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 5;791(1-2):39-44. |
N-Desmethyl imatinib
CAS: 404844-02-6 F: C28H29N7O W: 479.58
N-Desmethyl imatinib (Norimatinib) is a metabolite of Imatinib (HY-15463). Imatinib is a multi-target inhibitor of v-Abl
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.